218 related articles for article (PubMed ID: 32361312)
1. Generation of human iPS cell line IBCHi002-A from spinocerebellar ataxia type 3/Machado-Joseph disease patient's fibroblasts.
Ciolak A; Krzyzosiak WJ; Kozlowska E; Fiszer A
Stem Cell Res; 2020 May; 45():101796. PubMed ID: 32361312
[TBL] [Abstract][Full Text] [Related]
2. Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.
Hayer SN; Schelling Y; Huebener-Schmid J; Weber JJ; Hauser S; Schöls L
Stem Cell Res; 2018 Jul; 30():171-174. PubMed ID: 29936336
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells from a patient with spinocerebellar ataxia type 3.
Soong BW; Syu SH; Wen CH; Ko HW; Wu ML; Hsieh PC; Hwang SM; Lu HE
Stem Cell Res; 2017 Jan; 18():29-32. PubMed ID: 28395798
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 3.
Wang Y; Sun H; Wang Z; Yue Y; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2019 Dec; 41():101564. PubMed ID: 31639609
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Ouyang S; Xie Y; Xiong Z; Yang Y; Xian Y; Ou Z; Song B; Chen Y; Xie Y; Li H; Sun X
Stem Cells Dev; 2018 Jun; 27(11):756-770. PubMed ID: 29661116
[TBL] [Abstract][Full Text] [Related]
6. Generation of induced pluripotent stem cell line (ZZUi0026-A) from a patient with spinocerebellar ataxia type 3.
Fang J; Wang Y; Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Xu Y; Zhang X; Kan Q
Stem Cell Res; 2021 May; 53():102205. PubMed ID: 34087977
[TBL] [Abstract][Full Text] [Related]
7. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.
Ou Z; Luo M; Niu X; Chen Y; Xie Y; He W; Song B; Xian Y; Fan D; OuYang S; Sun X
Biomed Res Int; 2016; 2016():6701793. PubMed ID: 27847820
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell line (XHCSUi001-A) from urine cells of a patient with spinocerebellar ataxia type 3.
He L; Ye W; Chen Z; Wang C; Zhao H; Li S; Peng L; Han X; Zhou T; Li Z; Tang B; Jiang H
Stem Cell Res; 2019 Oct; 40():101555. PubMed ID: 31491691
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.
He L; Wang S; Peng L; Zhao H; Li S; Han X; Habimana JD; Chen Z; Wang C; Peng Y; Peng H; Xie Y; Lei L; Deng Q; Wan L; Wan N; Yuan H; Gong Y; Zou G; Li Z; Tang B; Jiang H
Transl Psychiatry; 2021 Sep; 11(1):479. PubMed ID: 34535635
[TBL] [Abstract][Full Text] [Related]
10. Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics.
Paulino R; Nóbrega C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108570
[TBL] [Abstract][Full Text] [Related]
11. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):589-92. PubMed ID: 27346191
[TBL] [Abstract][Full Text] [Related]
12. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
[TBL] [Abstract][Full Text] [Related]
13. Machado Joseph-Disease Is Rare in the Peruvian Population.
Cornejo-Olivas M; Solis-Ponce L; Araujo-Aliaga I; Milla-Neyra K; Ortega O; Illanes-Manrique M; Mazzetti P; Manrique-Enciso C; Cubas-Montecino D; Saraiva-Pereira ML; Jardim LB; Sarapura-Castro E
Cerebellum; 2023 Dec; 22(6):1192-1199. PubMed ID: 36323979
[TBL] [Abstract][Full Text] [Related]
14. Selective forces acting on spinocerebellar ataxia type 3/Machado-Joseph disease recurrency: A systematic review and meta-analysis.
Sena LS; Dos Santos Pinheiro J; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2021 Mar; 99(3):347-358. PubMed ID: 33219521
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3.
Hansen SK; Stummann TC; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Daechsel JC; Fog K; Hyttel P
Stem Cell Res; 2016 Sep; 17(2):306-317. PubMed ID: 27596958
[TBL] [Abstract][Full Text] [Related]
16. Establishment of human-induced pluripotent stem cell GZHMCi0011-A from peripheral blood mononuclear cells from a volunteer with 14/63 CAG repeats of the ATXN3 mutation.
Hongmei G; Xiaofang S; Bing S
Stem Cell Res; 2023 Oct; 72():103190. PubMed ID: 37866221
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cell line (ZZUi004-A) from urine sample of a patient with spinocerebellar ataxia type 3.
Wang Y; Shi C; Wang Z; Sun H; Yang Z; Zhang F; Liu Y; Liu H; Jiang C; Zhang S; Xu Y; Wen X
Stem Cell Res; 2018 Apr; 28():71-74. PubMed ID: 29444500
[TBL] [Abstract][Full Text] [Related]
18. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
19. Recent therapeutic prospects for Machado-Joseph disease.
Costa MDC
Curr Opin Neurol; 2020 Aug; 33(4):519-526. PubMed ID: 32657894
[TBL] [Abstract][Full Text] [Related]
20. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
